A Cost-effective Analysis of Short Duration Dual Anti-platelet Therapy (dapt) With a Bioabsorbable Polymer Stent Platform Versus Longer Duration Dapt With a Durable Polymer Drug-eluting Stent in a Patient Population Undergoing Elective Percutaneous Coronary Intervention